BuzzSparks.org

Skyline Ventures


Skyline Ventures, formed in 1997, is a nationally-known venture capital firm that specializes in investing in outstanding product-focused healthcare companies. Their areas of expertise include small molecule and protein therapeutics; medical...

Founded in 1997
Employees: 7
Homepage:

Palo Alto Office

94301 525 University Avenue
Suite 610

Palo Alto
Palo Alto
USA CA

Phone: 650-462-5800

Updated on Dec 15, 2008
Skyline Ventures at CrunchBase
Eric M Gordon Founder
John G. Freund Managing Director
Yasunori Kaneko Managing Director
Stephen J. Hoffman Managing Director
Past

July, 2013

Skyline Ventures invested $60M in Dicerna Pharmaceuticals as a Series C round

January, 2013

Skyline Ventures invested $28M in Crescendo Bioscience as a Series D round

October, 2012

Skyline Ventures invested $30M in Genocea Biosciences as a Series C round

May, 2012

Skyline Ventures invested $16.5M in Sutro Biopharma as a Series C round

February, 2012

Skyline Ventures invested $22.5M in Collegium Pharmaceutical as unattributed round

September, 2011

Skyline Ventures invested $16M in SI-BONE as unattributed round

January, 2011

Skyline Ventures invested $35M in Genocea Biosciences as a Series B round

November, 2010

Skyline Ventures invested $36.5M in Sutro Biopharma as a Series C round

August, 2010

Skyline Ventures invested $10.6M in SI-BONE as a Series B round

June, 2010

Skyline Ventures invested $45M in Tetraphase Pharmaceuticals as a Series C round

November, 2009

Skyline Ventures invested $1.4M in Calibra Medical as unattributed round

Skyline Ventures invested $50M in Calypso Medical as a Series E round

May, 2009

Skyline Ventures invested $50M in Proteon Therapeutics as a Series B round

February, 2009

Skyline Ventures invested $500K in SpinalMotion as a Series C round

August, 2008

Skyline Ventures invested $15M in Tetraphase Pharmaceuticals as a Series A round

Skyline Ventures invested $18.5M in InteKrin as a Series C round

May, 2008

Skyline Ventures invested $49.5M in NovaSys as unattributed round

April, 2008

Skyline Ventures invested $37M in Concert Pharmaceuticals as a Series C round

September, 2007

Skyline Ventures invested $12M in Proteon Therapeutics as a Series A round

July, 2007

Skyline Ventures invested $30M in Satiety as a Series D round

March, 2007

Skyline Ventures invested $50M in MAP Pharmaceuticals as a Series D round

November, 2006

Skyline Ventures invested $48.5M in Concert Pharmaceuticals as a Series B round

July, 2006

Skyline Ventures invested $10M in Concert Pharmaceuticals as a Series A round

May, 2006

Skyline Ventures invested $43.8M in Avidia as a Series C round

Skyline Ventures invested $35M in KAI Pharmaceuticals as a Series B round

December, 2004

Skyline Ventures invested $13M in Sirtris Pharmaceuticals as a Series A round

November, 2003

Skyline Ventures invested $27M in Applied Genetics Technologies Corporation as a Series B round

1997

Skyline Ventures was founded in 1997